Correlations between Cerebrospinal Fluid Biomarkers and Gray Matter Atrophy in Alzheimer's and Behavioural Variant Frontotemporal Dementia

Distinguishing between frontotemporal dementia (FTD) and Alzheimer's disease (AD) in their early stages remains a significant clinical challenge. Cerebrospinal fluid (CSF) biomarkers (total Tau, phosphorylated Tau, and beta-amyloid) are promising candidates for identifying early differences bet...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current Alzheimer research Jg. 21; H. 6; S. 371
Hauptverfasser:	Scianatico, Gaetano, Manippa, Valerio, Zaca, Domenico, Jovicich, Jorge, Tafuri, Benedetta, Rivolta, Davide, Logroscino, Giancarlo
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United Arab Emirates 01.01.2024
Schlagworte:	Aged Alzheimer Disease - cerebrospinal fluid Alzheimer Disease - pathology Amyloid beta-Peptides - cerebrospinal fluid Atrophy - pathology Biomarkers - cerebrospinal fluid Female Frontotemporal Dementia - cerebrospinal fluid Frontotemporal Dementia - diagnostic imaging Frontotemporal Dementia - pathology Gray Matter - diagnostic imaging Gray Matter - pathology Humans Magnetic Resonance Imaging Male Middle Aged tau Proteins - cerebrospinal fluid cerebrospinal fluid biomarkers voxel-based morphometry grey matter density Alzheimer’s disease Frontotemporal dementia MR structural imaging
ISSN:	1875-5828, 1875-5828
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!